BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10220535)

  • 1. Radionuclide techniques for myocardial viability and hibernation.
    Walton S
    Heart; 1999 Jan; 81(1):6-7. PubMed ID: 10220535
    [No Abstract]   [Full Text] [Related]  

  • 2. Radionuclide techniques for the assessment of myocardial viability and hibernation.
    Bax JJ; van der Wall EE; Harbinson M
    Heart; 2004 Aug; 90 Suppl 5(Suppl 5):v26-33. PubMed ID: 15254006
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved detection of viable myocardium with fluorodeoxyglucose-labeled single-photon emission computed tomography in a patient with hibernating myocardium: comparison with rest-redistribution thallium 201-labeled single-photon emission computed tomography.
    Bax JJ; Visser FC; Cornel JH; van Lingen A; Fioretti PM; Visser CA
    J Nucl Cardiol; 1997; 4(2 Pt 1):178-9. PubMed ID: 9115073
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
    Bax JJ; Wijns W
    J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging techniques in the assessment of myocardial hibernation.
    Underwood SR
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1209; author reply 1210-1. PubMed ID: 15197506
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.
    Bax JJ; Cornel JH; Visser FC; Fioretti PM; van Lingen A; Huitink JM; Elhendy A; Poldermans D; Roelandt JR; Visser CA
    J Nucl Med; 1998 Sep; 39(9):1481-6. PubMed ID: 9744328
    [No Abstract]   [Full Text] [Related]  

  • 7. New applications of myocardial perfusion imaging.
    DePuey EG
    Tex Heart Inst J; 1996; 23(2):122-7. PubMed ID: 8792543
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial viability. Assessment by cardiac scintigraphy.
    Gimple LW; Beller GA
    Cardiol Clin; 1994 May; 12(2):317-32. PubMed ID: 8033180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability in chronic ischaemic cardiomyopathy: need for timely revascularisation.
    Chareonthaitawee P; Barnes E; Rimoldi O; Camici PG; Burke MM; Khaghani A
    Eur J Nucl Med; 1999 Nov; 26(11):1521-2. PubMed ID: 10627177
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of reversible myocardial tissue injury (stunning) after thrombolytic therapy using radioisotope imaging techniques.
    Parodi O
    J Nucl Biol Med (1991); 1991; 35(2):63-5. PubMed ID: 1834191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
    Knapp WH
    Nuklearmedizin; 1995 Jun; 34(3):118-26. PubMed ID: 7630745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial viability. What does it mean and how do we measure it?
    Gould KL
    Circulation; 1991 Jan; 83(1):333-5. PubMed ID: 1984890
    [No Abstract]   [Full Text] [Related]  

  • 13. [18Fluoro-FDG SPECT for the demonstration of hibernating myocardium: an interim account].
    Alexander C; Schaefer A; Trampert L; Oberhausen E; Kirsch CM; Berberich R
    Nuklearmedizin; 1997 Jun; 36(4):125-30. PubMed ID: 9289698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial viability: contractile reserve or cell membrane integrity?
    Dilsizian V
    J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.
    Dilsizian V; Bacharach SL; Khin MM; Smith MF
    J Nucl Cardiol; 2001; 8(1):75-88. PubMed ID: 11182712
    [No Abstract]   [Full Text] [Related]  

  • 16. Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction.
    Yamagishi H; Akioka K; Takagi M; Tanaka A; Takeuchi K; Yoshikawa J; Ochi H
    Heart; 1999 Jan; 81(1):17-24. PubMed ID: 10220539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.
    Bax JJ; Poldermans D; Elhendy A; Boersma E; Rahimtoola SH
    Curr Probl Cardiol; 2001 Feb; 26(2):147-86. PubMed ID: 11276916
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium.
    Tsubokawa A; Lee JD; Shimizu H; Nakano A; Uzui H; Takeuchi M; Tsuchida T; Yonekura Y; Ishii Y; Ueda T
    J Nucl Med; 1997 Dec; 38(12):1835-7. PubMed ID: 9430454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear cardiology, Part IV: Viability.
    Mesotten L; Maes A; Hambye AS; Everaert H; Van den Maegdenbergh V; Franken P; Mortelmans L
    J Nucl Med Technol; 1999 Jun; 27(2):93-102; quiz 104-5. PubMed ID: 10353105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging modalities for detection of myocardial viability.
    Underwood R
    MAGMA; 1998 Sep; 6(2-3):137-9. PubMed ID: 9803388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.